Manufacturer record
Smayan Healthcare Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
8 batches manufactured by Smayan Healthcare Pvt. Ltd (Himachal Pradesh) were declared Not of Standard Quality between March 2022 and June 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: L5G174, Paracetamol Paediatric Oral Suspension IP (exp Jun 2027). Delhi (state lab) found it not of standard quality: Test For Assay (Content) Of Paracetamol. Listed in the June 2026 alert.
Records by type
8 records linked to Smayan Healthcare Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Paracetamol Paediatric Oral Suspension IP | Batch L5G174Mfg Jul 2025 · Exp Jun 2027 | Test For Assay (Content) Of ParacetamolAssay | DelhiState lab | Jun 2026 |
| Paracetamol Paediatric Oral Suspension IP | Batch L5G175Mfg Jul 2025 · Exp Jun 2027 | Test For Assay (Content) Of ParacetamolAssay | DelhiState lab | Jun 2026 |
| Adenosine Injection IP 6 mg/2ml | Batch I5K048Mfg Nov 2025 · Exp Oct 2027 | The sample does not conforms to I.P. 2022 with respect to the test for pHpH | CDTL, MumbaiCDSCO lab | Jun 2026 |
| Paracetamol Pediatric Oral Suspension IP | Batch L4H088Mfg Aug 2024 · Exp Jul 2026 | Assay for paracetamol does not comply as per IP 2022.Assay | DCL, TelanganaState lab | Jan 2026 |
| Ofloxacin, Ornidazole, Itraconazole & Clobetasol Propionate Cream (Derma-RX Cream) | Batch E3H021Mfg Aug 2023 · Exp Jul 2025 | Assay of Clobetasol PropionateAssay | CDL KolkataCDSCO lab | Oct 2023 |
| Ambroxol HCl, Terbutaline Sulphate, Guaiphenesin & Menthol Syrup (Toscof- TR) | Batch L3H148Mfg Aug 2023 · Exp Jul 2025 | Assay of MentholAssay | CDL KolkataCDSCO lab | Oct 2023 |
| Aceclofenac & Paracetamol Oral Suspension (SIGAFENAC-P) | Batch L3C152Mfg Mar 2023 · Exp Feb 2025 | Assay of Aceclofenac & ParacetamolAssay | CDL KolkataCDSCO lab | Oct 2023 |
| Lignocaine Hydrochloride Gel IP (LIGNOMARK JELLY) | Batch E1C060Mfg Mar 2021 · Exp Feb 2023 | AssayAssay | RDTL ChandigarhCDSCO lab | Mar 2022 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.